BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $875,579 | -19.3% | 23,207 | -2.6% | 0.12% | -14.0% |
| Q2 2023 | $1,085,100 | +29.9% | 23,817 | +15.6% | 0.14% | +26.5% |
| Q1 2023 | $835,413 | -14.8% | 20,597 | +7.1% | 0.11% | -17.5% |
| Q4 2022 | $980,392 | +0.7% | 19,235 | +6.3% | 0.14% | -8.1% |
| Q3 2022 | $974,000 | -9.3% | 18,087 | +8.1% | 0.15% | -3.2% |
| Q2 2022 | $1,074,000 | -4.4% | 16,735 | +15.5% | 0.15% | +10.8% |
| Q1 2022 | $1,123,000 | -2.8% | 14,485 | +7.6% | 0.14% | +4.5% |
| Q4 2021 | $1,155,000 | +13.1% | 13,460 | +6.0% | 0.13% | +7.3% |
| Q3 2021 | $1,021,000 | +20.5% | 12,700 | +20.7% | 0.12% | +24.0% |
| Q2 2021 | $847,000 | -1.6% | 10,525 | +3.2% | 0.10% | -7.4% |
| Q1 2021 | $861,000 | +143.9% | 10,200 | +131.8% | 0.11% | +125.0% |
| Q4 2020 | $353,000 | +50.2% | 4,400 | +50.4% | 0.05% | +33.3% |
| Q3 2020 | $235,000 | -10.0% | 2,925 | -3.3% | 0.04% | -18.2% |
| Q2 2020 | $261,000 | +6.5% | 3,025 | 0.0% | 0.04% | -17.0% |
| Q1 2020 | $245,000 | +11.4% | 3,025 | +15.2% | 0.05% | +35.9% |
| Q4 2019 | $220,000 | -3.9% | 2,625 | 0.0% | 0.04% | -9.3% |
| Q3 2019 | $229,000 | +0.9% | 2,625 | -5.6% | 0.04% | -2.3% |
| Q2 2019 | $227,000 | +80.2% | 2,780 | +78.8% | 0.04% | +76.0% |
| Q1 2019 | $126,000 | +15.6% | 1,555 | -6.0% | 0.02% | +4.2% |
| Q4 2018 | $109,000 | -14.8% | 1,655 | 0.0% | 0.02% | -4.0% |
| Q3 2018 | $128,000 | +4.9% | 1,655 | 0.0% | 0.02% | +8.7% |
| Q2 2018 | $122,000 | +13.0% | 1,655 | 0.0% | 0.02% | +15.0% |
| Q1 2018 | $108,000 | +0.9% | 1,655 | 0.0% | 0.02% | +81.8% |
| Q4 2017 | $107,000 | +161.0% | 1,655 | +152.7% | 0.01% | +120.0% |
| Q3 2017 | $41,000 | +2.5% | 655 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $40,000 | +17.6% | 655 | 0.0% | 0.00% | -42.9% |
| Q1 2017 | $34,000 | +17.2% | 655 | 0.0% | 0.01% | +16.7% |
| Q4 2016 | $29,000 | -6.5% | 655 | 0.0% | 0.01% | -14.3% |
| Q3 2016 | $31,000 | +3.3% | 655 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $30,000 | +11.1% | 655 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $27,000 | +8.0% | 655 | 0.0% | 0.01% | +16.7% |
| Q4 2015 | $25,000 | +56.2% | 655 | +31.0% | 0.01% | +50.0% |
| Q3 2015 | $16,000 | -54.3% | 500 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $35,000 | -27.1% | 500 | -28.6% | 0.01% | -27.3% |
| Q1 2015 | $48,000 | -7.7% | 700 | 0.0% | 0.01% | -8.3% |
| Q4 2014 | $52,000 | – | 700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |